Condition
Transthyretin (TTR) Amyloid Cardiomyopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Transthyretin (TTR) Amyloid Cardiomyopathy clinical trials that are recruiting, at sites in 2 countries (most in Italy (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Liver and Coagulation Markers in ATTR Cardiac Amyloidosis
This study tests liver function and blood-clotting markers in people with ATTR-CA to see if they reflect disease severity and progression.
-
TTR stabilizers and blood transthyretin amyloid aggregates in ATTR-CM patients
This research will test whether TTR-stabilizing drugs like tafamidis or acoramidis lower blood levels of transthyretin amyloid aggregates over time in people with ATTR-CM.
Related topics
Quick answers
How many Transthyretin (TTR) Amyloid Cardiomyopathy clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Italy (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.